Search Results - "pharmacokinetics"

The Pharmacokinetics of Beta-Lactam Antibiotics Using Scavenged Samples in Pediatric Intensive Care Patients: The EXPAT Kids Study Protocol by Stef Schouwenburg, Enno D. Wildschut, M. de Hoog, Birgit C.P. Koch, Alan Abdulla, Alan Abdulla

Connect to this object online.

A multicenter, phase I, pharmacokinetic study of osimertinib in cancer patients with normal renal function or severe renal impairment by Karthick Vishwanathan, Inmaculada Sanchez‐Simon, Bhumsuk Keam, Nicolas Penel, Maria deMiguel‐Luken, Doris Weilert, Andrew Mills, Marcelo Marotti, Martin Johnson, Alain Ravaud

Connect to this object online.

Simultaneous determination of pioglitazone and candesartan in human plasma by LC-MS/MS and its application to a human pharmacokinetic study by Vijaya Kumari Karra, Nageswara Rao Pilli, Jaswanth Kumar Inamadugu, J.V.L.N. Seshagiri Rao

Connect to this object online.

QSAR, simulation techniques, and ADMET/pharmacokinetics assessment of a set of compounds that target MAO-B as anti-Alzheimer agent by Abduljelil Ajala, Adamu Uzairu, Gideon A. Shallangwa, Stephen E. Abechi

Connect to this object online.

Rapid sensitive validated UPLCâMS method for determination of venlafaxine and its metabolite in rat plasma: Application to pharmacokinetic study by Sunil Kumar Dubey, R.N. Saha, Hemanth Jangala, S. Pasha

Connect to this object online.

Safety, pharmacokinetics, and food effect of sudapyridine (WX‐081), a novel anti‐tuberculosis candidate in healthy Chinese subjects by Chengyin Yu, Hongjie Qian, Qingqing Wu, Yang Zou, Qicheng Ding, Yuting Cai, Liyu Liang, Juncai Xu, Lei Li, Bin Zan, Yongguo Li, Yun Liu

Connect to this object online.

Prediction of CYP-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Modeling: A Case Study of Salbutamol and Fluvoxamine by Lara Marques, Nuno Vale

Connect to this object online.

Pharmacokinetics and outcome of tazobactam/piperacillin in Japanese patients undergoing low-flow continuous renal replacement therapy: dosage considerations by Kohama H, Ide T, Ikawa K, Morikawa N, Nishi S

Connect to this object online.

Clinical Pharmacology of Vinpocetine: Properties Revisited and Introduction of a Population Pharmacokinetic Model for Its Metabolite, Apovincaminic Acid (AVA) by Zvonimir Petric, Paulo Paixão, Augusto Filipe, José Guimarães Morais

Connect to this object online.

Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain by Young D. Kwon, Amarendra Pegu, Eun Sung Yang, Baoshan Zhang, Michael F. Bender, Mangaiarkarasi Asokan, Qingbo Liu, Krisha McKee, Bob C. Lin, Tracy Liu, Mark K. Louder, Reda Rawi, Mateo Reveiz, Andrew J. Schaub, Chen-Hsiang Shen, Nicole A. Doria-Rose, Paolo Lusso, John R. Mascola, Peter D. Kwong

Connect to this object online.

Investigation of inner ear drug delivery with a cochlear catheter in piglets as a representative model for human cochlear pharmacokinetics by Erdem Yildiz, Erdem Yildiz, Anselm J. Gadenstaetter, Anselm J. Gadenstaetter, Matthias Gerlitz, Matthias Gerlitz, Lukas D. Landegger, Lukas D. Landegger, Rudolfs Liepins, Michael Nieratschker, Michael Nieratschker, Rudolf Glueckert, Hinrich Staecker, Clemens Honeder, Clemens Honeder, Christoph Arnoldner, Christoph Arnoldner

Connect to this object online.

Age associations with tacrolimus and mycophenolic acid pharmacokinetics in stable Black and White kidney transplant recipients: Implications for health inequities by Kathleen M. Tornatore, Kristopher Attwood, Rocco C. Venuto, Brian Murray

Connect to this object online.

Mining Small Routine Clinical Data: A Population Pharmacokinetic Model and Optimal Sampling Times of Capecitabine and its Metabolites by Esther Oyaga-Iriarte, Asier Insausti, Lorea Bueno, Onintza Sayar, Azucena Aldaz

Connect to this object online.

Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia by Noriyuki Ishihara, Nobuhiro Nishimura, Kazuro Ikawa, Fumi Karino, Kiyotaka Miura, Hiroki Tamaki, Takahisa Yano, Takeshi Isobe, Norifumi Morikawa, Kohji Naora

Connect to this object online.

Pharmacokinetic interactions between fexuprazan, a potassium‐competitive acid blocker, and nonsteroidal anti‐inflammatory drugs in healthy males by Heejae Won, Eunwoo Kim, Jihye Chae, Hyejung Lee, Joo‐Youn Cho, In‐Jin Jang, Jae‐Yong Chung, Min‐Gul Kim, SeungHwan Lee

Connect to this object online.

Comparative pharmacokinetics of polymyxin B in critically ill elderly patients with extensively drug-resistant gram-negative bacteria infections by Juan Zeng, Bing Leng, Xiaoyan Guan, Shuangyan Jiang, Maoyu Xie, Wenying Zhu, Yue Tang, Lin Zhang, Jing Sha, Tengfei Wang, Min Ding, Nan Guo, Jinjiao Jiang

Connect to this object online.

Results from in vitro and in vivo studies evaluating the bioavailability, effects of food, and administration as crushed tablet suspension on vericiguat pharmacokinetics by Corina Becker, Michael Boettcher, Uwe Muenster, Stephanie Loewen, Maximilian Lobmeyer, Wolfgang Mueck

Connect to this object online.

Predicting pharmacodynamic effects through early drug discovery with artificial intelligence-physiologically based pharmacokinetic (AI-PBPK) modelling by Keheng Wu, Xue Li, Zhou Zhou, Youni Zhao, Mei Su, Zhuo Cheng, Xinyi Wu, Zhijun Huang, Xiong Jin, Jingxi Li, Mengjun Zhang, Jack Liu, Bo Liu

Connect to this object online.

Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis by Chen L, Yang Y, Wang X, Wang C, Lin W, Jiao Z, Wang Z

Connect to this object online.

Pharmacokinetics of gene recombined angiogenesis inhibitor Kringle 5 in vivo using 131I specific markers and SPECT/CT by Ge Yan, Danrong Yang, Yan Yu, Jianjun Xue, Yifan Jia, Xuanzi Sun, Boyu Wang, Zewei Zhao, Maode Wang

Connect to this object online.